TAK Biopharma IVS — Credit Rating and Financial Key Figures

TAK Biopharma IVS (CVR number: 37962872) is a company from KØBENHAVN. The company reported a net sales of 0.4 mDKK in 2019, demonstrating a growth of 84.9 % compared to the previous year. The operating profit percentage was poor at -5.8 % (EBIT: -0 mDKK), while net earnings were -22.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -23.8 %, which can be considered poor and Return on Equity (ROE) was -51.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -45.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. TAK Biopharma IVS's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.